National Action Plan for Combating Multidrug-Resistant Tuberculosis: Six–Month Progress Report and Future Direction
In this report, NIH and other U.S. Government agencies describe progress toward achieving the goals of the National Action Plan for Combating Multidrug-Resistant Tuberculosis (MDR-TB). Read the six-month progress report.
NIAID supports research to elucidate the mechanisms of drug resistance, identify new TB drug targets and candidate drugs, and evaluate novel TB drugs and optimal drug combinations in preclinical and clinical studies. View a series of illustrations that demonstrate the mechanism of TB drugs.